Together with the results of apoptosis flow cytometry analysis and western blotting, these data demonstrated that miR-106a-RARB could decrease apoptosis of thyroid cancer cells by inhibiting ASK1-p38 pathway. The gene discussed is RARB; the disease is thyroid gland carcinoma.